ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,274.75
0.20%
Dow Jones
44,722.06
-0.31%
Gold vs US Dollar
2,635.795
0.13%
Brent Oil
72.395
-0.08%
Bitcoin
96,404.95
4.82%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Spruce Biosciences Inc (SPRB)

  7. Spruce Biosciences Inc (SPRB) News

Spruce Biosciences (SPRB)

Spruce Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SPRB
DateTimeSourceHeadlineSymbolCompany
14/11/202422:45Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:SPRBSpruce Biosciences Inc
12/11/202411:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPRBSpruce Biosciences Inc
11/11/202413:00Business WireSpruce Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate UpdatesNASDAQ:SPRBSpruce Biosciences Inc
28/10/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPRBSpruce Biosciences Inc
28/10/202420:01Business WireSpruce Biosciences to Participate in the Guggenheim Securities Healthcare Innovation ConferenceNASDAQ:SPRBSpruce Biosciences Inc
03/09/202420:01Business WireSpruce Biosciences to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:SPRBSpruce Biosciences Inc
12/08/202420:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SPRBSpruce Biosciences Inc
12/08/202420:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPRBSpruce Biosciences Inc
12/08/202420:01Business WireSpruce Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate UpdatesNASDAQ:SPRBSpruce Biosciences Inc
18/06/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPRBSpruce Biosciences Inc
06/06/202412:00Business WireSpruce Biosciences Recognized as a Bay Area Best Place to WorkNASDAQ:SPRBSpruce Biosciences Inc
04/06/202423:27Business Wireスプルース・バイオサイエンスとHMNC Brain Health GmbH、大うつ病性障害（MDD）の治療法開発に向けた戦略的協働を発表NASDAQ:SPRBSpruce Biosciences Inc
04/06/202420:16Business WireSpruce Biosciences und HMNC Brain Health kündigen strategische Zusammenarbeit zur Entwicklung einer Behandlung für Major Depressive Disorder (MDD) anNASDAQ:SPRBSpruce Biosciences Inc
04/06/202420:16Business WireSpruce Biosciences et HMNC Brain Health annoncent une collaboration stratégique pour le développement d’un traitement du trouble dépressif majeur (TDM)NASDAQ:SPRBSpruce Biosciences Inc
04/06/202411:00Business WireSpruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder (MDD)NASDAQ:SPRBSpruce Biosciences Inc
03/06/202411:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPRBSpruce Biosciences Inc
03/06/202411:00Business WireSpruce Biosciences Presented Phase 2 POWER Study Results of Tildacerfont for the Treatment of Polycystic Ovary Syndrome at ENDO 2024NASDAQ:SPRBSpruce Biosciences Inc
24/05/202420:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPRBSpruce Biosciences Inc
24/05/202420:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPRBSpruce Biosciences Inc
24/05/202420:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPRBSpruce Biosciences Inc
24/05/202420:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPRBSpruce Biosciences Inc
24/05/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPRBSpruce Biosciences Inc
23/05/202420:05Business WireSpruce Biosciences to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:SPRBSpruce Biosciences Inc
22/05/202420:14Business WireSpruce Biosciences Announces Poster Presentations at the 2024 Annual Meeting of the Endocrine SocietyNASDAQ:SPRBSpruce Biosciences Inc
13/05/202420:09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SPRBSpruce Biosciences Inc
13/05/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPRBSpruce Biosciences Inc
13/05/202420:01Business WireSpruce Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesNASDAQ:SPRBSpruce Biosciences Inc
01/05/202420:05Business WireSpruce Biosciences to Participate in May Investor ConferencesNASDAQ:SPRBSpruce Biosciences Inc
30/04/202420:05Business WireSpruce Biosciences Announces Additional Poster Presentation at the Pediatric Endocrine Society 2024 Annual MeetingNASDAQ:SPRBSpruce Biosciences Inc
22/04/202420:05Business WireSpruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual MeetingNASDAQ:SPRBSpruce Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:SPRB

Your Recent History

NASDAQ
MTSLD
BIT
UC46D3
Unicredit Bank
AMEX
MSOX
AdvisorShares MSOS Daily...
BOV
KNHY11
Kinea High Yield Cri Fun...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Level 2 Lite

    1 year 35%, 2 years 45% and *3 years 60%

    *Across 3 years £2132.64 only £853.06